Evidence map›Paper›PMID 42129951›Full record

ArticleInternational journal of stem cells2026

cP1P Maintains Long-Term Pluripotency in Human Pluripotent Stem Cells.

Sang Hyeon Woo, Sehyun Chae, Byung-Ho Rhie, Won-Jun Jo, Young Jun Park, Myeong-Jun Choi, Viswanathaiah Matam, Suresh Ramakrishna, Daehee Hwang, Kye-Seong Kim

Abstract read
In one paragraph

Article in International journal of stem cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sang Hyeon WooDepartment of Biomedical Science, Graduate School of Biomedical Science and Engineering, Hanyang University, Seoul, Korea.ORCID https://orcid.org/0009-0002-3939-568X
Sehyun ChaeDivision of Chemical Engineering and Bioengineering, College of Art, Culture and Engineering, Kangwon National University, Chuncheon, Korea.ORCID https://orcid.org/0000-0001-6904-0623
Byung-Ho RhieInstitute of Medical Science, Kangwon National University, Chuncheon, Korea.ORCID https://orcid.org/0009-0007-8374-9461
Won-Jun JoDepartment of Biomedical Science, Graduate School of Biomedical Science and Engineering, Hanyang University, Seoul, Korea.ORCID https://orcid.org/0009-0006-1442-3321
Young Jun ParkR&D Center, Axceso Biopharma Co., Ltd., Yongin, Korea.ORCID https://orcid.org/0009-0009-9570-1574
Myeong-Jun ChoiR&D Center, Axceso Biopharma Co., Ltd., Yongin, Korea.ORCID https://orcid.org/0009-0004-5612-7809
Viswanathaiah MatamDepartment of Biomedical Science, Alliance School of Applied Engineering, Alliance University, Bengaluru, India.ORCID https://orcid.org/0009-0009-1804-753X
Suresh RamakrishnaDepartment of Biomedical Science, Graduate School of Biomedical Science and Engineering, Hanyang University, Seoul, Korea.ORCID https://orcid.org/0000-0002-4038-1085
Daehee HwangSchool of Biological Sciences, Seoul National University, Seoul, Korea.ORCID https://orcid.org/0000-0002-7553-0044
Kye-Seong KimDepartment of Biomedical Science, Graduate School of Biomedical Science and Engineering, Hanyang University, Seoul, Korea.ORCID https://orcid.org/0000-0001-5550-1660

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long-term culture of human pluripotent stem cells (hPSCs) can lead to spontaneous mutations, genomic abnormalities, and alterations in gene expression, thereby compromising their self-renewal and pluripotency. Thus, optimizing the long-term culture conditions of hPSCs is crucial. In this study, we introduce O-cyclic phytosphingosine-1-phosphate (cP1P, Axceso Biopharma Co. Ltd.), a novel culture additive structurally analogous to S1P, which markedly enhances hPSC self-renewal and survival. Our results demonstrate that cP1P supplementation promotes long-term proliferation of hPSCs by upregulating pluripotency markers and maintaining their ability to differentiate into cell types derived from the three germ layers. Furthermore, RNA-seq analysis reveals that cP1P alleviates long-term culture-induced upregulation of apoptosis- and chordate embryonic development-related genes, while preventing the downregulation of stem cell maintenance pathways. Collectively, these findings suggest that cP1P effectively supports the proliferation, pluripotency, and differentiation potential of hPSCs during both short- and long-term cultures.

Indexed as

Cyclic phytosphingosine-1-phosphateHuman pluripotent stem cellsLong-term culturePluripotency maintenanceTranscriptomic profiling

Identifiers

PMID42129951
PMCPMC13519551

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.